Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

NSE:INDRAMEDCO Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	13,564	12,447	10,987	8,882	6,134
Revenue Growth (YoY)	8.97%	13.29%	23.70%	44.80%	-26.17%
Cost of Revenue	8,627	5,040	4,630	4,059	3,257
Gross Profit	4,936	7,407	6,357	4,823	2,877
Selling, General & Admin	-	1,066	894.6	552.1	284.5
Other Operating Expenses	2,494	4,396	3,947	3,070	2,182
Operating Expenses	2,937	5,863	5,234	3,972	2,800
Operating Income	1,999	1,545	1,123	851.3	76.6
Interest Expense	-62.7	-10.6	-4.6	-6.1	-
Interest & Investment Income	-	168.9	100.3	31.2	6.8
Other Non Operating Income (Expenses)	226.5	-30	-38.2	-28	-33.4
EBT Excluding Unusual Items	2,163	1,673	1,181	848.4	50
Gain (Loss) on Sale of Assets	-	-11.7	-8.7	-57.7	-7.1
Pretax Income	2,163	1,661	1,172	790.7	42.9
Income Tax Expense	553.3	421.5	310.3	204.5	19.6
Net Income	1,610	1,240	861.5	586.2	23.3
Net Income to Common	1,610	1,240	861.5	586.2	23.3
Net Income Growth	29.87%	43.89%	46.96%	2415.88%	-94.66%
Shares Outstanding (Basic)	92	92	92	92	92
Shares Outstanding (Diluted)	92	92	92	92	92
Shares Change (YoY)	0.01%	-	-	-	-
EPS (Basic)	17.56	13.52	9.40	6.39	0.25
EPS (Diluted)	17.56	13.52	9.40	6.39	0.25
EPS Growth	29.88%	43.87%	47.07%	2456.00%	-94.75%
Free Cash Flow	1,204	1,308	998.9	648.2	58.5
Free Cash Flow Per Share	13.13	14.26	10.90	7.07	0.64
Dividend Per Share	4.500	4.500	3.000	2.500	-
Dividend Growth	-	50.00%	20.00%	-	-
Gross Margin	36.39%	59.51%	57.86%	54.30%	46.90%
Operating Margin	14.74%	12.41%	10.22%	9.59%	1.25%
Profit Margin	11.87%	9.96%	7.84%	6.60%	0.38%
Free Cash Flow Margin	8.88%	10.51%	9.09%	7.30%	0.95%
EBITDA	2,443	1,907	1,477	1,160	371
EBITDA Margin	18.01%	15.32%	13.44%	13.06%	6.05%
D&A For EBITDA	443.3	362.8	354	308.3	294.4
EBIT	1,999	1,545	1,123	851.3	76.6
EBIT Margin	14.74%	12.41%	10.22%	9.59%	1.25%
Effective Tax Rate	25.58%	25.37%	26.48%	25.86%	45.69%
Revenue as Reported	13,790	12,616	11,087	8,913	6,141

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.